Summary
Antibodies to tubulin, the fundamental protein of microtubules, were studied by radioimmunoassay in patients with Type 1 (insulin-dependent) diabetes of varying duration and in healthy control subjects. Elevated levels of anti-tubulin antibodies were found in 46% of 28 patients with Type 1 diabetes of recent onset (⩽ 6 months) and in only 6.2% of 64 patients with long-standing Type 1 diabetes (duration 6–43 years). None of 34 DR3-positive normal subjects and none of 20 Type 2 (non-insulin-dependent) diabetic patients were positive for anti-tubulin antibodies. Anti-tubulin antibody levels were elevated in two out of 26 first-degree relatives of Type 1 diabetic patients. The specificity of the detection of anti-tubulin antibodies was demonstrated by (1) dilution of the sera, (2) competitive binding experiments between labelled and unlabelled tubulin, (3) immunoblotting. Antibodies to tubulin were elevated in 60% of patients with islet cell surface antibodies and there was a significant association between anti-tubulin antibodies and islet-cell surface antibodies. These antibodies, however, recognize different specificities, since adsorption of islet cell surface antibody by rat islets did riot alter the anti-tubulin antibody activity. Elevated anti-actin antibody responses were found in two out of 17 and one out of 26 patients with recent onset and long-standing Type 1 diabetes, respectively. In conclusion, anti-tubulin antibodies are detected in a high proportion of patients with diabetes of recent onset, are associated with islet cell surface antibodies and like islet cell surface antibodies decrease or disappear during the course of the disease. Therefore, elevation of antitubulin antibodies could represent another ‘marker’ of the immunological features of Type 1 diabetes. However, these findings, together with our previous observation of an elevation of anti-tubulin antibodies in autoimmune thyroid disorders, indicate a wider involvement of autoimmunity with tubulin and suggest that similar autoimmune phenomena could develop in Type 1 diabetes and some other diseases.
Article PDF
Similar content being viewed by others
References
Bottazzo GF, Florin-Christiensen A, Doniach D (1974) Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2: 1279–1282
Lernmark A, Freedman ZR, Hofmann C, Rubinstein AM, Steiner DF, Jackson RL, Winter RJ, Traisman HS (1978) Islet cell surface antibodies in juvenile diabetes mellitus. N Engl J Med 299: 375–380
Van Obberghen E, Davis G, Somers G, Ravazola M, Malaisse-Lagae F, Malaisse WJ (1974) Dynamics of insulin secretion and microtubular-microfilamentous systems. IV. Effect of colchicine upon sulphonyl urea induced insulin secretion. Eur J Clin Invest 4: 307–312
Rousset B, Wolff J (1980) Lactoperoxidase-tubulin interactions. J Biol Chem 255: 2514–2523
Bernier-Valentin F, Rousset B (1982) Interaction of tubulin with rat liver membranes. J Biol Chem 257: 7092–7099
Bernier-Valentin F, Aunis D, Rousset B (1983) Evidence for tubulin binding sites on cellular membranes: plasma membranes, mitochondrial membranes and secretory granule membranes. J Cell Biol 97: 209–216
Rousset B, Bernier-Valentin F, Poncet C, Orgiazzi J, Madec AM, Monier JC, Mornex R (1983) Anti-tubulin antibodies in autoimmune thyroid disorders. Clin Exp Immunol 52: 325–332
Vialettes B, Di Campo-Rougerie C, Lassman V, Vague Ph (1983) Comparaison de divers types d'anticorps anti-ilôts dans le diabète en fonction de la cause et de la durée d'évolution. Presse Med 12: 2303–2306
Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350–4354
Karsenti E, Guilbert B, Bornens M, Avrameas S (1977) Antibodies to tubulin in normal non-immunized animals. Proc Natl Acad Sci USA 74: 3997–4001
Mead GM, Cowin P, Whitehouse JMA (1980) Anti-tubulin antibody in healthy adults and patients with infectious mononucleosis and its relationship to smooth muscle antibody. Clin Exp Immunol 39: 328–336
Rousset B, Bernier-Valentin F, Wolff J, Roux B (1983) Alterations in tubulin immunoreactivity: relation to secondary structure. Eur J Biochem 131: 31–39
Bhattacharyya B, Wolff J (1975) Membrane-bound tubulin in brain and thyroid tissue. J Biol Chem 250: 7639–7646
Lernmark A, Hägglöf B, Freedman ZR, Irvine J, Ludvigsson J, Holmgren G (1981) A prospective analysis of antibodies reacting with pancreatic islet cells in insulin-dependent diabetic children. Diabetologia 20: 471–474
Bastenie PA (1975) Diabéte et maladies auto-immunitaires. Diabete Metab 1: 3–6
Bottazzo GF, Mann JI, Thorogood M, Baum JD, Doniach D (1978) Autoimmunity in juvenile diabetics and their families. Br Med J 2: 165–168
Gray RJ, Borsey DQ, Seth J, Herd R, Brown NS, Clarke BF (1980) Prevalence of subclinical thyroid failure in insulin dependent diabetes. J Clin Endocrinol Metab 50: 1034–1037
Yoon JW, Austin M, Onodera T, Notkins AL (1979) Virus induced diabetes mellitus. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 300: 1173–1179
Christy M, Green A, Chuistau B, Kromann H, Nerup J, Platz P, Thomsen M, Ryden LP, Svejgaard A (1979) Studies of the HLA system and insulin-dependent diabetes mellitus. Diabetes Care 2: 209–214
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rousset, B., Vialettes, B., Bernier-Valentin, F. et al. Anti-tubulin antibodies in recent onset Type 1 (insulin-dependent) diabetes mellitus: comparison with islet cell antibodies. Diabetologia 27, 427–432 (1984). https://doi.org/10.1007/BF00273905
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00273905